Advertisement

Index by author

November 01, 1982; Volume 10,Issue 6

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Darrow, W R
1. You have access
  A study of methylphenidate in man with respect to its major metabolite.
  E Redalieu, M F Bartlett, L M Waldes, W R Darrow, H Egger and W E Wagner
  
  Drug Metabolism and Disposition November 1982, 10 (6) 708-709;
Darwin, W D
1. You have access
  Analytical controls in drug metabolic studies. II. Artifact formation during chloroform extraction of drugs and metabolites with amine substituents.
  E J Cone, W F Buchwald and W D Darwin
  
  Drug Metabolism and Disposition November 1982, 10 (6) 561-567;
Diamond, G L
1. You have access
  Salicylate enhancement of renal glucuronide conjugation and tubular excretory transfer of phenols.
  G L Diamond, M W Anders, L M Tremaine and A J Quebbemann
  
  Drug Metabolism and Disposition November 1982, 10 (6) 573-578;
Dudley, K H
1. You have access
  5-ethyl-5-phenylhydantoin N-glucuronide, the major urinary metabolite of 5-ethyl-5-phenylhydantoin (Nirvanol) in the dog.
  J H Maguire, T C Butler and K H Dudley
  
  Drug Metabolism and Disposition November 1982, 10 (6) 595-598;
Duprat, J
1. You have access
  Main metabolites of 1-(2-chloroethyl)-3-[1'-(5'-p-nitrobenzoyl-2',3'-isopropylidene)-alpha, beta-D-ribofuranosyl]-1-nitrosourea and 1-(2-chloroethyl)-3-(2',3', 4'-tri-O-acetyl-alpha, beta-D-ribopyranosyl)-1-nitrosourea in rats.
  J C Madelmont, M F Moreau, D Godeneche, J Duprat, R Plagne and G Meyniel
  
  Drug Metabolism and Disposition November 1982, 10 (6) 662-666;